Matches in Wikidata for { <http://www.wikidata.org/entity/Q35552265> ?p ?o ?g. }
- Q35552265 description "2003 nî lūn-bûn" @default.
- Q35552265 description "2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q35552265 description "2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված" @default.
- Q35552265 description "2003年の論文" @default.
- Q35552265 description "2003年論文" @default.
- Q35552265 description "2003年論文" @default.
- Q35552265 description "2003年論文" @default.
- Q35552265 description "2003年論文" @default.
- Q35552265 description "2003年論文" @default.
- Q35552265 description "2003年论文" @default.
- Q35552265 description "2003年论文" @default.
- Q35552265 description "2003年论文" @default.
- Q35552265 description "2003年论文" @default.
- Q35552265 description "2003年论文" @default.
- Q35552265 description "2003年论文" @default.
- Q35552265 description "2003년 논문" @default.
- Q35552265 description "article científic" @default.
- Q35552265 description "article scientific" @default.
- Q35552265 description "article scientifique" @default.
- Q35552265 description "articol științific" @default.
- Q35552265 description "articolo scientifico" @default.
- Q35552265 description "artigo científico" @default.
- Q35552265 description "artigo científico" @default.
- Q35552265 description "artigo científico" @default.
- Q35552265 description "artikel ilmiah" @default.
- Q35552265 description "artikull shkencor" @default.
- Q35552265 description "artikulong pang-agham" @default.
- Q35552265 description "artykuł naukowy" @default.
- Q35552265 description "artículo científico publicado en 2003" @default.
- Q35552265 description "artículu científicu espublizáu en 2003" @default.
- Q35552265 description "bilimsel makale" @default.
- Q35552265 description "bài báo khoa học" @default.
- Q35552265 description "mokslinis straipsnis" @default.
- Q35552265 description "naučni članak" @default.
- Q35552265 description "scienca artikolo" @default.
- Q35552265 description "scientific article published on December 2003" @default.
- Q35552265 description "scientific article published on December 2003" @default.
- Q35552265 description "scientific article published on December 2003" @default.
- Q35552265 description "teaduslik artikkel" @default.
- Q35552265 description "tieteellinen artikkeli" @default.
- Q35552265 description "tudományos cikk" @default.
- Q35552265 description "vedecký článok" @default.
- Q35552265 description "vetenskaplig artikel" @default.
- Q35552265 description "videnskabelig artikel" @default.
- Q35552265 description "vitenskapelig artikkel" @default.
- Q35552265 description "vitskapeleg artikkel" @default.
- Q35552265 description "vědecký článek" @default.
- Q35552265 description "wetenschappelijk artikel" @default.
- Q35552265 description "wissenschaftlicher Artikel" @default.
- Q35552265 description "επιστημονικό άρθρο" @default.
- Q35552265 description "мақолаи илмӣ" @default.
- Q35552265 description "мақолаи илмӣ" @default.
- Q35552265 description "наукова стаття, опублікована в грудні 2003" @default.
- Q35552265 description "научна статия" @default.
- Q35552265 description "научная статья" @default.
- Q35552265 description "научни чланак" @default.
- Q35552265 description "научни чланак" @default.
- Q35552265 description "מאמר מדעי" @default.
- Q35552265 description "مقالة علمية نشرت في ديسمبر 2003" @default.
- Q35552265 description "ডিসেম্বর ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q35552265 description "บทความทางวิทยาศาสตร์" @default.
- Q35552265 description "სამეცნიერო სტატია" @default.
- Q35552265 name "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 name "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 name "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 name "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 type Item @default.
- Q35552265 label "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 label "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 label "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 label "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 prefLabel "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 prefLabel "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 prefLabel "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 prefLabel "Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study" @default.
- Q35552265 P1433 Q35552265-BBAF4EAD-6A89-4D6B-A5FB-196F57EFA453 @default.
- Q35552265 P1476 Q35552265-B45F363E-FDEA-4502-B235-7CD0E043C317 @default.
- Q35552265 P2093 Q35552265-0A9A5330-79C7-452A-9FD5-38FE703B93D2 @default.
- Q35552265 P2093 Q35552265-298DF75C-4F7A-4F35-9916-E90528FD94AE @default.
- Q35552265 P2093 Q35552265-30A27EBA-4CA0-42B4-9743-6A4804A399B9 @default.
- Q35552265 P2093 Q35552265-68F5C558-3C86-4370-A321-12FD647A108C @default.
- Q35552265 P2093 Q35552265-6EAF781B-F24A-4B0D-87C2-CE485A9B6DCF @default.
- Q35552265 P2093 Q35552265-866930EF-53F8-4EF1-9853-1DFD02239509 @default.
- Q35552265 P2093 Q35552265-8E4AFCA1-4CEF-495B-8B86-B24BB5C2A36F @default.
- Q35552265 P2093 Q35552265-B3BE34EC-E44E-44A6-A562-448E9899F7FF @default.
- Q35552265 P2093 Q35552265-D8093936-459C-4E21-A094-203D1BCA98D8 @default.
- Q35552265 P2093 Q35552265-DAEEC1C2-BC81-40F0-BFD7-90F50656E865 @default.
- Q35552265 P2093 Q35552265-DB1E99B6-BD58-4338-BF71-6324510DD769 @default.
- Q35552265 P2860 Q35552265-01E9F2C1-8E7D-46A4-A857-BD792EB67A4D @default.
- Q35552265 P2860 Q35552265-0AF72452-55FB-4179-8EAE-DB90179D99E4 @default.
- Q35552265 P2860 Q35552265-116A735D-B4DB-425D-9001-DA901BE5B593 @default.
- Q35552265 P2860 Q35552265-28FBDC7A-6F1F-4178-96F2-3F49FB3757B1 @default.
- Q35552265 P2860 Q35552265-296F6D4D-34B7-4C92-B0EE-43BA0ED30A1A @default.
- Q35552265 P2860 Q35552265-31E743B8-2DC5-45FC-878C-A0C86A2A83A4 @default.
- Q35552265 P2860 Q35552265-37277CCF-6484-4B53-92A1-86B6A44C1F2A @default.
- Q35552265 P2860 Q35552265-374F5604-5394-41E4-850B-36DA5C4CED33 @default.
- Q35552265 P2860 Q35552265-38C8BA3D-A294-45FF-BAB8-25F27AAC5346 @default.
- Q35552265 P2860 Q35552265-4CF0FEF5-F4C1-4A01-A1A1-ACAB7D3FA3FC @default.
- Q35552265 P2860 Q35552265-4EC31755-1DFE-474C-97C2-8D3CA22BF63C @default.
- Q35552265 P2860 Q35552265-52957EFF-4A0F-4745-8F0A-9406114B5885 @default.